Anticoagulants

Citations 1-5 of 5 total displayed.

Most recent content (1 Nov 2009):

Original Articles
Epidemiology of Subtherapeutic Anticoagulation in the United States

Adam J. Rose, Al Ozonoff, Richard W. Grant, Lori E. Henault, and Elaine M. Hylek
Circ Cardiovasc Qual Outcomes 2009;2:591-597; published online before print as doi:10.1161/CIRCOUTCOMES.109.862763 [Abstract] [Full text]  

Past content (since Nov 2008):

Original Articles
Cost-Effectiveness of Genotype-Guided Warfarin Dosing for Patients With Atrial Fibrillation

Amanda R. Patrick, Jerry Avorn, and Niteesh K. Choudhry
Circ Cardiovasc Qual Outcomes 2009;2:429-436; published online before print as doi:10.1161/CIRCOUTCOMES.108.808592 [Abstract] [Full text]  

Original Articles
Should Patient Characteristics Influence Target Anticoagulation Intensity for Stroke Prevention in Nonvalvular Atrial Fibrillation?: The ATRIA Study

Daniel E. Singer, Yuchiao Chang, Margaret C. Fang, Leila H. Borowsky, Niela K. Pomernacki, Natalia Udaltsova, and Alan S. Go
Circ Cardiovasc Qual Outcomes 2009;2:297-304; published online before print as doi:10.1161/CIRCOUTCOMES.108.830232 [Abstract] [Full text]  

Editorials
Anticoagulation Control in Atrial Fibrillation: Optimizing Risks and Benefits

Alawi A. Alsheikh-Ali and N.A. Mark Estes, III
Circ Cardiovasc Qual Outcomes 2008;1:72-73, doi:10.1161/CIRCOUTCOMES.108.827329 [Full text]  

Original Articles
Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial Fibrillation: A Systematic Review

Yi Wan, Carl Heneghan, Rafael Perera, Nia Roberts, Jennifer Hollowell, Paul Glasziou, Clare Bankhead, and Yongyong Xu
Circ Cardiovasc Qual Outcomes 2008;1:84-91; published online before print as doi:10.1161/CIRCOUTCOMES.108.796185 [Abstract] [Full text]